首页 >

COV-047 搜索结果

  • ねね[BRJ-009]吉澤玲子[COV-047]作品及种子

    栗緒ねね[BRJ-009]吉澤玲子[COV-047]作品及种子搜索下载
    2020-08-17 12:30:00

    栗緒ねね[BRJ-009]发行于2009-09-04时长68分钟出品商是BRAD-J,BRJ-009作品种子搜索下载,吉澤玲子[COV-047]发行于2009-05-25时长70分钟出品商是コンセント,COV-047作品种子搜索下载

  • The first Chinese national standards for SARS-CoV

    The first Chinese national standards for SARS-CoV
    2021-05-03 16:00:00

    evaluating the immunogenicity of vaccines and the potency testing of therapeutic antibody products against coronavirus disease 2019 (COVID-19), the first Chinese national standards for SARS-CoV-2 neutralizing antibody were ...

  • CovMy -

    CovMy -
    2022-03-03 04:38:00

    CovMy ​ ​ 查看详细资料 ​关注她​发私信 动态 回答4 视频0 ...4,047 人也赞同了该回答 我的人生是在男人的凝视中展开的。 在 G 城的

  • 综述:新冠肺炎的炎症风暴到底有何特殊之处?

    综述:新冠肺炎的炎症风暴到底有何特殊之处?
    2020-04-06 16:00:00

    新型冠状病毒(SARS-CoV-2)自入侵我国以来,给我国乃至世界各国造成了巨大的经济损失,也严重威胁着世界各国人民的生命安全。之前的推送已经对免疫系统中各个组分在病毒感染中的作用进行了概述,本次我们将会着重探究一个问题:新冠肺炎的炎症风...

  • A Study of Ad26.COV2.S in Adults (COVID-19) - Full Text

    A Study of Ad26.COV2.S in Adults (COVID-19) - Full Text
    2020-06-17 16:00:00

    The purpose of the study is to assess the safety, reactogenicity, and immunogenicity of Ad26.COV2.S at 2 dose levels, administered intramuscularly (IM) as a single-dose or 2-dose schedule, with a single booster vac...

  • 2019冠状病毒病(COVID-19):医务人员的职业健康问题 -

    2019冠状病毒病(COVID-19):医务人员的职业健康问题 -
    2022-01-27 16:00:00

    ●若采用不基于检测的策略,即根据症状出现后及症状缓解后时间(或无症状者检测结果阳性的时间)的策略,感染严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的医务人员在满足停用防控措施的标准后即可复工。但对于无症状或有轻至中度疾病的免疫...

  • COVID Live - Coronavirus Statistics -

    COVID Live - Coronavirus Statistics -
    2022-06-01 16:00:00

    36,984 (0.2%) Serious or Critical Show Graph Show Statistics Closed Cases 534,908,782 Cases which had an outcome: 528,548,308 (99%) Recovered / Discharged 6,360,474 (1%) Deaths Show Graph ...

  • Case studies of SARS-CoV-2 treated with favipiravir

    Case studies of SARS-CoV-2 treated with favipiravir
    2020-08-03 16:00:00

    DOI: 10.1016/j.ijid.2020.08.047 年份: 2020 收藏 引用 批量引用 报错 分享 全部来源 求助全文 Elsevier ResearchGate 相似文献Investigation of the Frequency of Adverse Effects in Patients Treated with Favipiravir as SARS-CoV-2...

  • 针对SARS-CoV-2的无ADE效应的中和抗体

    针对SARS-CoV-2的无ADE效应的中和抗体
    2022-03-15 14:40:00

    针对sars-cov-2的无ade效应的中和抗体技术领域::1.本发明涉及针对sars-cov-2新冠病毒的无ade效应的中和抗体及其抗原结合片段,以及制备和使用所述中和抗体及其抗原结合片段的方法。背景技术:::2.2019年全球流行的冠状病毒疾病(covid-19)...

  • SARS-CoV-2 infection rates of antibody-positive compared

    SARS-CoV-2 infection rates of antibody-positive compared
    2021-04-10 03:06:01

    individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection is an urgent ...baseline positive cohort of 8278 participants, collectively contributing 2 047 113 person-days of follow-up...

热门用户

1 NewPPP 85283篇
2 PPP知乎 555篇
3 PPP头条 287篇
4 中政智信 278篇
5 森墨传媒 264篇
6 ppp观点 264篇
7 PPP门户 245篇
8 中投协APIF 215篇
9 中国PPP知行汇 213篇
10 PPP操作实务 203篇